Sodium/iodide symporter is expressed in the majority of seminomas and embryonal testicular carcinomas

Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer Cells

(2012) Zhi Liu et al.   PLoS One

Epigenetics of thyroid cancer and novel therapeutic targets

(2011) Diego Russo et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Spermatocytic seminoma: toward further understanding of pathogenesis

(2011) Leendert HJ Looijenga   JOURNAL OF PATHOLOGY

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

(2010) M. Hingorani et al.   CURRENT CANCER DRUG TARGETS

Testicular germ cell tumors: pathogenesis, diagnosis and treatment

(2010) Christian Winter et al.   Nature Reviews Endocrinology

Endogenous NIS Expression in Triple-Negative Breast Cancers

(2009) Corinne Renier et al.   ANNALS OF SURGICAL ONCOLOGY

Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors

(2009) W. Castillo-Avila et al.   CLINICAL CANCER RESEARCH

Expression of the Sodium/Iodide Symporter in Human Prostate Adenocarcinoma

(2009) Michele Navarra et al.   UROLOGY

Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo

(2008) M Celano et al.   ENDOCRINE-RELATED CANCER

Germ Cell Tumors of the Gonads: A Selective Review Emphasizing Problems in Drug Resistance and Current Therapy Options

(2008) Mark Schrader et al.   ONCOLOGY